YK-11 Genetix Pharma

Product Overview

YK-11 by Genetix Pharma is an experimental selective androgen receptor modulator (SARM)-related compound known for its unique steroidal structure and potential myostatin-inhibiting properties. Unlike traditional SARMs, YK-11 is often described as a hybrid compound due to its steroid-derived structure and selective androgen receptor activity. Manufactured by Genetix Pharma, this product is intended strictly for research or medically supervised investigational contexts.

Key Features

• Contains YK-11 (myostine) compound
• Manufactured by Genetix Pharma
• Experimental SARM-related compound
• Associated with myostatin and androgen receptor activity
• Pharmaceutical-style formulation standards

How YK-11 Works

YK-11 acts as a partial agonist of the androgen receptor and has been studied for its potential influence on follistatin expression, which may affect myostatin regulation pathways linked to muscle growth. Research suggests it differs structurally from traditional SARMs and may behave more like a steroidal compound. Human clinical data remains extremely limited.